{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:07:16Z","timestamp":1793848036329,"version":"4.6.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473008"],"award-info":[{"award-number":["82473008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173223"],"award-info":[{"award-number":["82173223"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Chromosomal instability (CIN), a hallmark of malignancy, remains poorly understood in clear cell renal cell carcinoma (ccRCC). Here, we identify spindle and kinetochore-associated protein 3 (SKA3) as a critical regulator of CIN in ccRCC. BAP1 loss-of-function mutations, prevalent in ccRCC, drive aberrant SKA3 overexpression. Mechanistically, BAP1 deubiquitinates nuclear receptor co-repressor 1 (NCOR1) to enhance its recruitment to the\n                    <jats:italic>SKA3<\/jats:italic>\n                    promoter, thereby repressing\n                    <jats:italic>SKA3<\/jats:italic>\n                    transcription. Additionally, BAP1-mediated histone H2AK119 deubiquitination at the\n                    <jats:italic>TRIM25<\/jats:italic>\n                    promoter activates the expression of\n                    <jats:italic>TRIM25<\/jats:italic>\n                    , facilitating ubiquitin-proteasome-mediated degradation of SKA3. BAP1 deficiency disrupts both regulatory pathways, leading to aberrant accumulation of SKA3, which fuels CIN and correlates with metastasis progression and poor prognosis. In conclusion, our findings establish dysfunction of the BAP1-SKA3 axis as a molecular driver of CIN in ccRCC and suggest SKA3 as a potential therapeutic target for BAP1-mutant ccRCC.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-09076-3","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:55:16Z","timestamp":1784087716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["BAP1 deficiency-induced SKA3 promotes clear cell renal cell carcinoma malignant progression by regulating chromosomal instability"],"prefix":"10.1038","volume":"17","author":[{"given":"Yueyang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6581-9987","authenticated-orcid":false,"given":"Chong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4787-2925","authenticated-orcid":false,"given":"Zhiyong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5954-2857","authenticated-orcid":false,"given":"Honghe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"9076_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41576-024-00761-7","volume":"26","author":"X Chen","year":"2025","unstructured":"Chen X, Agustinus AS, Li J, DiBona M, Bakhoum SF. Chromosomal instability as a driver of cancer progression. Nat Rev Genet. 2025;26:31\u201346.","journal-title":"Nat Rev Genet"},{"key":"9076_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-020-2698-6","volume":"587","author":"TBK Watkins","year":"2020","unstructured":"Watkins TBK, Lim EL, Petkovic M, Elizalde S, Birkbak NJ, Wilson GA, et al. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature. 2020;587:126\u201332.","journal-title":"Nature"},{"key":"9076_CR3","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41586-023-06464-z","volume":"620","author":"J Li","year":"2023","unstructured":"Li J, Hubisz MJ, Earlie EM, Duran MA, Hong C, Varela AA, et al. Non-cell-autonomous cancer progression from chromosomal instability. Nature. 2023;620:1080\u20138.","journal-title":"Nature"},{"key":"9076_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature25432","volume":"553","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum SF, Ngo B, Laughney AM, Cavallo JA, Murphy CJ, Ly P, et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature. 2018;553:467\u201372.","journal-title":"Nature"},{"key":"9076_CR5","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1016\/j.devcel.2021.07.006","volume":"56","author":"MR Ippolito","year":"2021","unstructured":"Ippolito MR, Martis V, Martin S, Tijhuis AE, Hong C, Wardenaar R, et al. Gene copy-number changes and chromosomal instability induced by aneuploidy confer resistance to chemotherapy. Dev Cell. 2021;56:2440\u201354.e6.","journal-title":"Dev Cell"},{"key":"9076_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113266","volume":"42","author":"S Kandala","year":"2023","unstructured":"Kandala S, Ramos M, Voith von Voithenberg L, Diaz-Jimenez A, Chocarro S, Keding J, et al. Chronic chromosome instability induced by Plk1 results in immune suppression in breast cancer. Cell Rep. 2023;42:113266.","journal-title":"Cell Rep"},{"key":"9076_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70164","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Su M, Chen Y, Cui L, Xia W, Xu R, et al. EHMT2-mediated R-loop formation promotes the malignant progression of prostate cancer via activating Aurora B. Clin Transl Med. 2025;15:e70164.","journal-title":"Clin Transl Med"},{"key":"9076_CR8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cell.2024.12.005","volume":"188","author":"J Espejo Valle-Inclan","year":"2025","unstructured":"Espejo Valle-Inclan J, De Noon S, Trevers K, Elrick H, van Belzen I, Zumalave S, et al. Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution. Cell. 2025;188:352\u201370.e22.","journal-title":"Cell"},{"key":"9076_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molcel.2023.11.002","volume":"84","author":"A Mazzagatti","year":"2024","unstructured":"Mazzagatti A, Engel JL, Ly P. Boveri and beyond: chromothripsis and genomic instability from mitotic errors. Mol Cell. 2024;84:55\u201369.","journal-title":"Mol Cell"},{"key":"9076_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2216700120","volume":"120","author":"PF Cosper","year":"2023","unstructured":"Cosper PF, Hrycyniak LCF, Paracha M, Lee DL, Wan J, Jones K, et al. HPV16 E6 induces chromosomal instability due to polar chromosomes caused by E6AP-dependent degradation of the mitotic kinesin CENP-E. Proc Natl Acad Sci USA. 2023;120:e2216700120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9076_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41556-024-01558-w","volume":"27","author":"WT Lu","year":"2025","unstructured":"Lu WT, Zalmas LP, Bailey C, Black JRM, Martinez-Ruiz C, Pich O, et al. TRACERx analysis identifies a role for FAT1 in regulating chromosomal instability and whole-genome doubling via Hippo signalling. Nat Cell Biol. 2025;27:154\u201368.","journal-title":"Nat Cell Biol"},{"key":"9076_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100929","volume":"14","author":"Q Ma","year":"2021","unstructured":"Ma Q, Wang J, Qi J, Peng D, Guan B, Zhang J, et al. Increased chromosomal instability characterizes metastatic renal cell carcinoma. Transl Oncol. 2021;14:100929.","journal-title":"Transl Oncol"},{"key":"9076_CR13","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s43018-023-00584-1","volume":"4","author":"L Perelli","year":"2023","unstructured":"Perelli L, Carbone F, Zhang L, Huang JK, Le C, Khan H, et al. Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer. Nat Cancer. 2023;4:984\u20131000.","journal-title":"Nat Cancer"},{"key":"9076_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.canlet.2015.08.013","volume":"369","author":"J Peng","year":"2015","unstructured":"Peng J, Ma J, Li W, Mo R, Zhang P, Gao K, et al. Stabilization of MCRS1 by BAP1 prevents chromosome instability in renal cell carcinoma. Cancer Lett. 2015;369:167\u201374.","journal-title":"Cancer Lett"},{"key":"9076_CR15","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1038\/onc.2015.24","volume":"34","author":"N Kanu","year":"2015","unstructured":"Kanu N, Gr\u00f6nroos E, Martinez P, Burrell RA, Yi Goh X, Bartkova J, et al. SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair. Oncogene. 2015;34:5699\u2013708.","journal-title":"Oncogene"},{"key":"9076_CR16","doi-asserted-by":"publisher","first-page":"16538","DOI":"10.1073\/pnas.1414789111","volume":"111","author":"SS Wang","year":"2014","unstructured":"Wang SS, Gu YF, Wolff N, Stefanius K, Christie A, Dey A, et al. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis. Proc Natl Acad Sci USA. 2014;111:16538\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9076_CR17","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1158\/2159-8290.CD-17-0292","volume":"7","author":"YF Gu","year":"2017","unstructured":"Gu YF, Cohn S, Christie A, McKenzie T, Wolff N, Do QN, et al. Modeling renal cell carcinoma in mice: Bap1 and Pbrm1 inactivation drive tumor grade. Cancer Discov. 2017;7:900\u201317.","journal-title":"Cancer Discov"},{"key":"9076_CR18","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/emboj.2009.96","volume":"28","author":"TN Gaitanos","year":"2009","unstructured":"Gaitanos TN, Santamaria A, Jeyaprakash AA, Wang B, Conti E, Nigg EA. Stable kinetochore-microtubule interactions depend on the Ska complex and its new component Ska3\/C13Orf3. EMBO J. 2009;28:1442\u201352.","journal-title":"EMBO J"},{"key":"9076_CR19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.molcel.2012.03.005","volume":"46","author":"AA Jeyaprakash","year":"2012","unstructured":"Jeyaprakash AA, Santamaria A, Jayachandran U, Chan YW, Benda C, Nigg EA, et al. Structural and functional organization of the Ska complex, a key component of the kinetochore-microtubule interface. Mol Cell. 2012;46:274\u201386.","journal-title":"Mol Cell"},{"key":"9076_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2163-3","volume":"10","author":"Y Hou","year":"2019","unstructured":"Hou Y, Wang Z, Huang S, Sun C, Zhao J, Shi J, et al. SKA3 promotes tumor growth by regulating CDK2\/P53 phosphorylation in hepatocellular carcinoma. Cell Death Dis. 2019;10:929.","journal-title":"Cell Death Dis"},{"key":"9076_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03104-6","volume":"11","author":"W Gao","year":"2020","unstructured":"Gao W, Zhang Y, Luo H, Niu M, Zheng X, Hu W, et al. Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis. Cell Death Dis. 2020;11:919.","journal-title":"Cell Death Dis"},{"key":"9076_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13046-023-02842-7","volume":"42","author":"Y Chen","year":"2023","unstructured":"Chen Y, Xu X, Wang Y, Zhang Y, Zhou T, Jiang W, et al. Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation. J Exp Clin Cancer Res. 2023;42:265.","journal-title":"J Exp Clin Cancer Res"},{"key":"9076_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1012999","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Huang L, Li J, Yang W, Li W, Long Q, et al. Immunological role and prognostic value of the SKA family in pan-cancer analysis. Front Immunol. 2023;14:1012999.","journal-title":"Front Immunol"},{"key":"9076_CR24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","volume":"33","author":"AM Taylor","year":"2018","unstructured":"Taylor AM, Shih J, Ha G, Gao GF, Zhang X, Berger AC, et al. Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell. 2018;33:676\u201389.e3.","journal-title":"Cancer Cell"},{"key":"9076_CR25","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/ng1861","volume":"38","author":"SL Carter","year":"2006","unstructured":"Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet. 2006;38:1043\u20138.","journal-title":"Nat Genet"},{"key":"9076_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25\u20139.","journal-title":"Nat Genet"},{"key":"9076_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00363-w","volume":"7","author":"A Ogden","year":"2017","unstructured":"Ogden A, Rida PC, Aneja R. Prognostic value of CA20, a score based on centrosome amplification-associated genes, in breast tumors. Sci Rep. 2017;7:262.","journal-title":"Sci Rep"},{"key":"9076_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ccell.2016.12.004","volume":"31","author":"JM Sheltzer","year":"2017","unstructured":"Sheltzer JM, Ko JH, Replogle JM, Habibe Burgos NC, Chung ES, Meehl CM, et al. Single-chromosome gains commonly function as tumor suppressors. Cancer Cell. 2017;31:240\u201355.","journal-title":"Cancer Cell"},{"key":"9076_CR29","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cell.2018.03.043","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic S, Xu H, Litchfield K, Rowan A, Horswell S, Chambers T, et al. Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal. Cell. 2018;173:595\u2013610.e11.","journal-title":"Cell"},{"key":"9076_CR30","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ng.2699","volume":"45","author":"Y Sato","year":"2013","unstructured":"Sato Y, Yoshizato T, Shiraishi Y, Maekawa S, Okuno Y, Kamura T, et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet. 2013;45:860\u20137.","journal-title":"Nat Genet"},{"key":"9076_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s43018-021-00316-3","volume":"3","author":"Y Xie","year":"2022","unstructured":"Xie Y, Sahin M, Sinha S, Wang Y, Nargund AM, Lyu Y, et al. SETD2 loss perturbs the kidney cancer epigenetic landscape to promote metastasis and engenders actionable dependencies on histone chaperone complexes. Nat Cancer. 2022;3:188\u2013202.","journal-title":"Nat Cancer"},{"key":"9076_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215885","volume":"547","author":"LE Langbein","year":"2022","unstructured":"Langbein LE, El Hajjar R, He S, Sementino E, Zhong Z, Jiang W, et al. BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma. Cancer Lett. 2022;547:215885.","journal-title":"Cancer Lett"},{"key":"9076_CR33","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","volume":"10","author":"M Carbone","year":"2020","unstructured":"Carbone M, Harbour JW, Brugarolas J, Bononi A, Pagano I, Dey A, et al. Biological mechanisms and clinical significance of BAP1 mutations in human cancer. Cancer Discov. 2020;10:1103\u201320.","journal-title":"Cancer Discov"},{"key":"9076_CR34","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1101\/gad.318436.118","volume":"32","author":"L Yu","year":"2018","unstructured":"Yu L, Jearawiriyapaisarn N, Lee MP, Hosoya T, Wu Q, Myers G, et al. BAP1 regulation of the key adaptor protein NCoR1 is critical for \u03b3-globin gene repression. Genes Dev. 2018;32:1537\u201349.","journal-title":"Genes Dev"},{"key":"9076_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrg2736","volume":"11","author":"V Perissi","year":"2010","unstructured":"Perissi V, Jepsen K, Glass CK, Rosenfeld MG. Deconstructing repression: evolving models of co-repressor action. Nat Rev Genet. 2010;11:109\u201323.","journal-title":"Nat Rev Genet"},{"key":"9076_CR36","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.7150\/ijbs.50186","volume":"16","author":"Q Peng","year":"2020","unstructured":"Peng Q, Xu H, Xiao M, Wang L. The small molecule PSSM0332 disassociates the CRL4A(DCAF8) E3 ligase complex to decrease the ubiquitination of NcoR1 and inhibit the inflammatory response in a mouse sepsis-induced myocardial dysfunction model. Int J Biol Sci. 2020;16:2974\u201388.","journal-title":"Int J Biol Sci"},{"key":"9076_CR37","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-020-03133-3","volume":"590","author":"RJ Quinton","year":"2021","unstructured":"Quinton RJ, DiDomizio A, Vittoria MA, Kot\u00fdnkov\u00e1 K, Ticas CJ, Patel S, et al. Whole-genome doubling confers unique genetic vulnerabilities on tumour cells. Nature. 2021;590:492\u20137.","journal-title":"Nature"},{"key":"9076_CR38","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41586-020-03114-6","volume":"590","author":"Y Cohen-Sharir","year":"2021","unstructured":"Cohen-Sharir Y, McFarland JM, Abdusamad M, Marquis C, Bernhard SV, Kazachkova M, et al. Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition. Nature. 2021;590:486\u201391.","journal-title":"Nature"},{"key":"9076_CR39","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1158\/1078-0432.CCR-20-4185","volume":"27","author":"F Atrafi","year":"2021","unstructured":"Atrafi F, Boix O, Subbiah V, Diamond JR, Chawla SP, Tolcher AW, et al. A phase I study of an MPS1 inhibitor (BAY 1217389) in combination with paclitaxel using a novel randomized continual reassessment method for dose escalation. Clin Cancer Res. 2021;27:6366\u201375.","journal-title":"Clin Cancer Res"},{"key":"9076_CR40","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41586-023-06084-7","volume":"619","author":"AS Agustinus","year":"2023","unstructured":"Agustinus AS, Al-Rawi D, Dameracharla B, Raviram R, Jones B, Stransky S, et al. Epigenetic dysregulation from chromosomal transit in micronuclei. Nature. 2023;619:176\u201383.","journal-title":"Nature"},{"key":"9076_CR41","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.devcel.2021.07.009","volume":"56","author":"DA Lukow","year":"2021","unstructured":"Lukow DA, Sausville EL, Suri P, Chunduri NK, Wieland A, Leu J, et al. Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies. Dev Cell. 2021;56:2427\u201339.e4.","journal-title":"Dev Cell"},{"key":"9076_CR42","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.1038\/sj.emboj.7601426","volume":"25","author":"A Hanisch","year":"2006","unstructured":"Hanisch A, Sillj\u00e9 HH, Nigg EA. Timely anaphase onset requires a novel spindle and kinetochore complex comprising Ska1 and Ska2. EMBO J. 2006;25:5504\u201315.","journal-title":"EMBO J"},{"key":"9076_CR43","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.cub.2017.03.060","volume":"27","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Sivakumar S, Chen Y, Gao H, Yang L, Yuan Z, et al. Ska3 phosphorylated by Cdk1 binds Ndc80 and recruits Ska to kinetochores to promote mitotic progression. Curr Biol. 2017;27:1477\u201384.e4.","journal-title":"Curr Biol"},{"key":"9076_CR44","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202208018","volume":"222","author":"A Rahi","year":"2023","unstructured":"Rahi A, Chakraborty M, Agarwal S, Vosberg KM, Agarwal S, Wang AY, et al. The Ndc80-Cdt1-Ska1 complex is a central processive kinetochore-microtubule coupling unit. J Cell Biol. 2023;222:e202208018.","journal-title":"J Cell Biol"},{"key":"9076_CR45","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1007\/s11010-025-05242-x","volume":"480","author":"X Zheng","year":"2025","unstructured":"Zheng X, Sun Z, Wang S, Liu Q, Zhu B, Ren Z, et al. SKA3 promotes lung adenocarcinoma progression via the EGFR\/E2F1\/SKA3\/integrin \u03b21 signaling loop. Mol Cell Biochem. 2025;480:4213\u20134226.","journal-title":"Mol Cell Biochem"},{"key":"9076_CR46","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/15384101.2022.2145817","volume":"22","author":"Z Li","year":"2023","unstructured":"Li Z, Liu J, Peng H, Li C, Liu Y, Xie W. SKA1 is overexpressed in laryngocarcinoma and modulates cell growth via P53 signaling pathway. Cell Cycle. 2023;22:693\u2013704.","journal-title":"Cell Cycle"},{"key":"9076_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj7446","volume":"385","author":"S Martin","year":"2024","unstructured":"Martin S, Scorzoni S, Cordone S, Mazzagatti A, Beznoussenko GV, Gunn AL, et al. A p62-dependent rheostat dictates micronuclei catastrophe and chromosome rearrangements. Science. 2024;385:eadj7446.","journal-title":"Science"},{"key":"9076_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj8691","volume":"385","author":"M Di Bona","year":"2024","unstructured":"Di Bona M, Chen Y, Agustinus AS, Mazzagatti A, Duran MA, Deyell M, et al. Micronuclear collapse from oxidative damage. Science. 2024;385:eadj8691.","journal-title":"Science"},{"key":"9076_CR49","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.3390\/cancers16183191","volume":"16","author":"P Rida","year":"2024","unstructured":"Rida P, Baker S, Saidykhan A, Bown I, Jinna N. FOXM1 transcriptionally co-upregulates centrosome amplification and clustering genes and is a biomarker for poor prognosis in androgen receptor-low triple-negative breast cancer. Cancers. 2024;16:3191.","journal-title":"Cancers"},{"key":"9076_CR50","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jtho.2025.06.020","volume":"20","author":"M Carbone","year":"2025","unstructured":"Carbone M, Minaai M, Kittaneh M, Krausz T, Miettinen MM, Pan Hammarstr\u00f6m Q, et al. Clinical and pathologic phenotyping of mesotheliomas developing in carriers of germline BAP1 mutations. J Thorac Oncol. 2025;20:1683\u201398.","journal-title":"J Thorac Oncol"},{"key":"9076_CR51","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.jtho.2025.07.132","volume":"20","author":"X Wu","year":"2025","unstructured":"Wu X, Hernandez FV, Wang H, Wang R, Shiffka S, Shah N, et al. Prospective analysis of mesotheliomas in subjects with BAP1 cancer syndrome: clinical characteristics and epigenetic correlates of disease. J Thorac Oncol. 2025;20:1699\u2013715.","journal-title":"J Thorac Oncol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09076-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09076-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09076-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:03:04Z","timestamp":1791432184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09076-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9076"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09076-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and its subsequent revisions. Animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Zhejiang University (Ethics Approval No. ZJU20240940), and all methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"874"}}